Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.60 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.60 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.60 |
| ▸ | TTR | P02766 | 3/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.60 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30340348 | 1.00 | PTGS2 (0.60) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| SCHEMBL4166639 | 0.98 | PTGS2 (0.58) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| SCHEMBL2763623 | 0.88 | PTGS2 (0.54) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| SCHEMBL30340032 | 0.86 | PTGS1 (0.58) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| SCHEMBL6951492 | 0.86 | KDM4E (0.50) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| SCHEMBL741474 | 0.84 | INPPL1 (0.59) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| Resveratrol SCHEMBL27678698 | 0.82 | PTGS1 (0.79) | PTGS2CYP1A1CYP1B1TTRALOX5 | |
| SCHEMBL4454764 | 0.78 | INPPL1 (0.71) | CA1CA2BLMINPPL1INPP5A | |
| SCHEMBL25194538 | 0.77 | CYP3A4 (0.68) | MEN1MAPTKMT2ACYP1A2TP53 | |
| SCHEMBL4736118 | 0.75 | CYP1A1 (0.66) | PTGS2CYP1A1CYP1B1TTRALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11622920-B2 | Delivery system for active agents | SYMRISE AG (DE) | 2023-04-11 | — | — | US | claimed |
| EP-3383354-B1 | DELIVERY SYSTEM FOR ACTIVE AGENTS | SYMRISE AG (DE) | 2023-03-22 | — | — | EP | claimed |
| EP-3081207-B1 | USE OF A LIPOSOME COMPOSITION | SYMRISE AG (DE) | 2022-09-21 | — | — | EP | claimed |
| US-20180353392-A1 | DELIVERY SYSTEM FOR ACTIVE AGENTS | SYMRISE AG (DE) | 2018-12-13 | — | — | US | claimed |
| EP-3383354-A1 | DELIVERY SYSTEM FOR ACTIVE AGENTS | Symrise AG (DE) | 2018-10-10 | — | — | EP | claimed |
| CN-108366933-A | Active agent delivery system | 西姆莱斯股份公司 | 2018-08-03 | — | — | CN | claimed |
| WO-2017092818-A1 | DELIVERY SYSTEM FOR ACTIVE AGENTS | SYMRISE AG (DE) | 2017-06-08 | — | — | WO | claimed |
| WO-2016166038-A1 | WHITENING COMPOSITIONS | SYMRISE AG (DE) | 2016-10-20 | — | — | WO | claimed |
| EP-3081207-A1 | WHITENING COMPOSITIONS | Symrise AG (DE) | 2016-10-19 | — | — | EP | claimed |
| US-8465973-B2 | Topical compositions containing phosphorylated polyphenols | ESTEE LAUDER COORDINATION CENTER N.V. (BE) | 2013-06-18 | — | — | US | claimed |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | claimed |
| US-11622920-B2 | Delivery system for active agents | SYMRISE AG (DE) | 2023-04-11 | — | — | US | disclosed |
| EP-3383354-B1 | DELIVERY SYSTEM FOR ACTIVE AGENTS | SYMRISE AG (DE) | 2023-03-22 | — | — | EP | disclosed |
| CN-109481422-B | Graphene oxide electrothermal film transdermal patch | 广西中医药大学 | 2022-11-11 | — | — | CN | disclosed |
| EP-3081207-B1 | USE OF A LIPOSOME COMPOSITION | SYMRISE AG (DE) | 2022-09-21 | — | — | EP | disclosed |
| US-20090247490-A1 | Topical Compositions Containing Phosphorylated Polyphenols | DECLERCQ LIEVE | 2009-10-01 | — | — | US | disclosed |
| WO-2009105294-A2 | TOPICAL COMPOSITIONS AND METHODS FOR WHITENING SKIN | ELC MANAGEMENT LLC (US) | 2009-08-27 | — | — | WO | disclosed |
| US-20080095866-A1 | delayed delivery of the polyphenol to keratinous tissues, such as skin, hair and nails, with enzymes of the keratinous tissue dephosphorylating the polyphenol, and returning it to its native active form | AJINOMOTO OMNICHEM S.A. (BE) | 2008-04-24 | — | — | US | disclosed |
| EP-1799228-A1 | TOPICAL COMPOSITIONS CONTAINING PHOSPHORYLATED POLYPHENOLS | Ajinomoto Omnichem S.A. (BE) | 2007-06-27 | — | — | EP | disclosed |
| WO-2006029484-A1 | TOPICAL COMPOSITIONS CONTAINING PHOSPHORYLATED POLYPHENOLS | AJINOMOTO OMNICHEM S.A. (BE) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247490-A1 | Topical Compositions Containing Phosphorylated Polyphenols | PPP5C, CHAMP1, PLK1 | PTGS2 4023/4885CYP1A1 2169/4885CYP1B1 2766/4885 |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | CUTA, LRAT, RARA | PTGS2 2396/4885CYP1A1 1737/4885CYP1B1 1935/4885 |
| US-20080095866-A1 | delayed delivery of the polyphenol to keratinous tissues, such as skin, hair and nails, with enzymes of the keratinous tissue dephosphorylating the polyphenol, and returning it to its native active form | KRT18, DUSP6, PPP5C | PTGS2 3776/4885CYP1A1 836/4885CYP1B1 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.